Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells

FEBS Letters

Volumn 584, Issue 8, 2010, Pages 1469-1475

  Yeom, Seon Yong ^a   Jang, Hye Lim ^a   Lee, Sook Ja ^a   Kim, Eunhee ^b   Son, Hee Jung ^c   Kim, Byoung Gie ^c   Park Chaehwa, C ^a  

^a Samsung Medical Center   (South Korea)

^b Chungnam National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cell death; Cervical carcinoma cell; Invasion; Yeast two hybrid analysis

Indexed keywords

DOXORUBICIN; MASPIN; SERINE PROTEINASE; TESTISIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER RESISTANCE; CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CANCER;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PROTEIN BINDING; SERINE ENDOPEPTIDASES; SERPINS; UTERINE CERVICAL NEOPLASMS;

EID: 77951299137     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.02.072     Document Type: Article

References (31)

1. Hooper J.D., Nicol D.L., Dickinson J.L., Eyre H.J., Scarman A.L., Normyle J.F., Stuttgen M.A., Douglas M.L., Loveland K.A., Sutherland G.R., Antalis T.M. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Res. 1999, 59:3199-3205.
2. Hooper J.D., Bowen N., Marshall H., Cullen L.M., Sood R., Daniels R., Stuttgen M.A., Normyle J.F., Higgs D.R., Kastner D.L., Ogbourne S.M., Pera M.F., Jazwinska E.C., Antalis T.M. Localization, expression and genomic structure of the gene encoding the human serine protease testisin. Biochim. Biophys. Acta 2000, 1492:63-71.
3. Honda A., Yamagata K., Sugiura S., Watanabe K., Baba T. A mouse serine protease TESP5 is selectively included into lipid rafts of sperm membrane presumably as a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 2002, 277:16976-16984.
4. Tang T., Kmet M., Corral L., Vartanian S., Tobler A., Papkoff J. Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo. Cancer Res. 2005, 65:868-878.
5. Schneider S.S., Schick C., Fish K.E., Miller E., Pena J.C., Treter S.D., Hui S.M., Silverman G.A. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl. Acad. Sci. USA 1995, 92:3147-3151.
6. Zou Z., Anisowicz A., Hendrix M.J., Thor A., Neveu M., Sheng S., Rafidi K., Seftor E., Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529.
7. Sheng S., Carey J., Seftor E.A., Dias L., Hendrix M.J., Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 1996, 93:11669-11674.
8. Machtens S., Serth J., Bokemeyer C., Bathke W., Minssen A., Kollmannsberger C., Hartmann J., Knuchel R., Kondo M., Jonas U., Kuczyk M. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int. J. Cancer 2001, 95:337-342.
9. Kim S., Han J., Kim J., Park C. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res. 2004, 64:6900-6905.
10. Zhang M., Shi Y., Magit D., Furth P.A., Sager R. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene 2000, 19:6053-6058.
11. Latha K., Zhang W., Cella N., Shi H.Y., Zhang M. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell. Biol. 2005, 25:1737-1748.
12. Jiang N., Meng Y., Zhang S., Mensah-Osma E., Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002, 21:4089-4098.
13. Shi H.Y., Zhang W., Liang R., Abraham S., Kittrell F.S., Medina D., Zhang M. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 2001, 61:6945-6951.
14. Ryu S.W., Chae S.K., Kim E. Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. Biochem. Biophys. Res. Commun. 2000, 279:6-10.
15. Kim K., Ryu K., Kho Y., Park C. Effects of NF-κB inhibitors and its implication on NK/T cell lymphoma cells. Br. J. Haematol. 2005, 131:59-66.
16. Liu J., Yin S., Reddy N., Spencer C., Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 2004, 64:1703-1711.
17. Borensztajn K.S., Spek C.A. Protease-activated receptors, apoptosis and tumor growth. Pathophysiol. Haemost. Thromb. 2008, 36:137-147.
18. Autefage H., Albinet V., Garcia V., Berges H., Nicolau M.L., Therville N., Altié M.F., Caillaud C., Levade T., Andrieu-Abadie N. Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner. J. Biol. Chem. 2009, 284:11507-11516.
19. Hartkamp J., Carpenter B., Roberts S.G. The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol. Cell 2010, 37:159-171.
20. Wilson T.J., Singh R.K. Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochim. Biophys. Acta 2008, 1785:85-95.
21. Wang W., Mize G.J., Zhang X., Takayama T.K. Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1. Int. J. Cancer 2010, 126:599-610.
22. Sheng S., Truong B., Fredrickson D., Wu R., Pardee A.B., Sager R. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc. Natl. Acad. Sci. USA 1998, 95:499-504.
23. Yin S., Lockett J., Meng Y., Biliran H., Blouse G.E., Li X., Reddy N., Zhao Z., Lin X., Anagli J., Cher M.L., Sheng S. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 2006, 66:4173-4181.
24. Bailey C.M., Khalkhali-Ellis Z., Kondo S., Margaryan N.V., Seftor R.E., Wheaton W.W., Amir S., Pins M.R., Schutte B.C., Hendrix M.J. Mammary serine protease inhibitor (maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J. Biol. Chem. 2005, 280:34210-34217.
25. Blacque O.E., Worrall D.M. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. 2002, 277:10783-10788.
26. Yin S., Li X., Meng Y., Finley R.L., Sakr W., Yang H., Reddy N., Sheng S. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J. Biol. Chem. 2005, 280:34985-34996.
27. Li X., Yin S., Meng Y., Sakr W., Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 2006, 66:9323-9329.
28. Sheng S., Pemberton P.A., Sager R. Production, purification, and characterization of recombinant maspin proteins. J. Biol. Chem. 1994, 269:30988-30993.
29. McGowen R., Biliran H., Sager R., Sheng S. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res. 2000, 60:4771-4778.
30. Maass N., Hojo T., Ueding M., Lüttges J., Klöppel G., Jonat W., Nagasaki K. Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 2001, 7:812-817.
31. Sood A.K., Fletcher M.S., Gruman L.M., Coffin J.E., Jabbari S., Khalkhali-Ellis Z., Arbour N., Seftor E.A., Hendrix M.J. The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 2002, 8:2924-2932.